У нас вы можете посмотреть бесплатно Roquefort Therapeutics announced a proposed acquisition of the exclusive worldwide licence to AO-252 или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
In this interview on The Watchlist, incoming chairman Sotirios Stergiopoulos discusses the science behind AO-252, its differentiated mechanism targeting DNA damage repair and immune pathways, and its potential across multiple solid tumours including ovarian, prostate, and triple-negative breast cancer. To book a CEO interview with ADVFN through The Market Link email:matthew.collom@themarketlink.com At The Market Link, we are a strategic digital marketing and investor connectivity agency. We bridge the gap between publicly traded companies and the global investment community. While traditional firms often focus on administrative compliance or institutional outreach, we specialize in investor engagement at scale. We treat your corporate story like a high-growth brand, using data-driven strategies to reach, educate, and convert the modern self-directed investor.